I am delighted to welcome you to our Spring 2021 newsletter.

Like every other organisation across the country COVID-19 has had a major impact on the Bionics Institute. It truly has highlighted the importance of medical research, and the significant role it plays in lessening the impact of disease and maintaining our health. Thanks to the resilience of the amazing people here at the Bionics Institute and the work they do, our research has been maintained throughout this difficult time. I couldn’t be prouder of what they have been able to achieve.

I would like to officially welcome Ann Fazakerley as our new Head of Philanthropy. Ann brings a wealth of experience to the Institute and it is great to have her on board.

In this newsletter we look at the pioneering work that James Fallon and his team are doing with the vagus nerve. Their bold research is meeting our goals of creating game-changing outputs that have real world impact and have put us at the forefront of developing peripheral nerve medical devices.

Over the last 30 years our teams have developed some extraordinary skills in how to make electrodes and devices at the nano scale. Through the launch of our new medical device prototyping facility, Neo-Bionica, we can now take those skills and translate them all the way through to the clinic.

Read full newsletter 

Robert Klupacs

CEO, Bionics Institute